SISB INVESTMENT ADVISERS (UK) LTD
Institutional investor · Portfolio as of Q3 2020
SEC EDGAR SourceSEC Filings
SB INVESTMENT ADVISERS (UK) LTD manages $11.6B across 4 positions as of Q3 2020. Top holdings: UBER (69.6%), GH (13.5%), RLAY (10.2%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.
Q3 2020 Summary
Added 1 new position, exited 2. Top move: RLAY (NEW, conviction 100). Portfolio: $11.6B across 4 positions.
Top holdings by portfolio weight
UBER69.64%
GH13.48%
RLAY10.21%
VIR6.67%
WORK0.00%
TXG0.00%
Portfolio allocation by GICS sector
Technology69.64%
Healthcare30.36%
Behavioral investing profile
7-dimension quality assessment
Below Average(1.5 / 5.0)
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Upgrade to Pro to see the worst-performing positions.
View plansCost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Holdings4 positions
Activity:
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
UBER TECHNOLOGIES INC | 222.2M | $8.1B | 69.6% | $46.38 | -23.61% | 6 qtrssince 2019-Q2 | Unchanged 0 |
GUARDANT HEALTH INC | 14M | $1.6B | 13.5% | $40.56 | +174.28% | 8 qtrssince 2018-Q4 | Unchanged 0 |
RELAY THERAPEUTICS INC | 27.9M | $1.2B | 10.2% | $39.98 | 0.00% | 1 qtr | New 100 |
VIR BIOTECHNOLOGY INC | 22.6M | $776.4M | 6.7% | $12.12 | +211.30% | 4 qtrssince 2019-Q4 | Unchanged 0 |
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer